| Abbreviation | Definition |
| 8-OH-dG | 8-hydroxy-2’-deoxyguanosine |
| AGEs | Advanced glycation end-products |
| AlaGln | Alanyl-glutamine |
| CAPD | Continuous ambulatory peritoneal dialysis |
| CKD | Chronic kidney disease |
| CRP | C-reactive protein |
| CSR | Cytoprotective cellular stress responses |
| CV | Cardiovascular |
| ESRD | End-stage renal disease |
| GDPs | Glucose degradation products |
| HD | Hemodialysis |
| IL-6 | Interleukin-6 |
| MCP-1 | Monocyte chemotactic peptide-1 |
| MDA | Malondialdehyde |
| NAC | N-acetylcysteine |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NOS | Nitric oxide synthase |
| OS | Oxidative stress |
| PD | Peritoneal dialysis |
| PM | Peritoneal membrane |
| PMC | Peritoneal mesothelial cell |
| RAGE | Receptor for AGEs |
| ROS | Reactive oxygen species |
| RRF | Residual renal function |
| RRT | Renal replacement therapy |
| TBARS | Thiobarbituric acid reactive substances |
| TGF-β | Tumor growth factor-β |
| TNF-α | Tumor necrosis factor-α |
| VEGF | Vascular endothelial growth factor |